Cidara Therapeutics, Inc (CDTX) insider trading
Every open-market stock purchase and sale by Cidara Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $2.2M over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Ra Capital Management L.p. (Insider), $100M, 15 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.2M (1 sale). Last close $221.38 on Jan 5, 2026.
Recent CDTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | Ra Capital Management L.p. (Insider) | Sold (not open market) | $1.4B |
| Jan 7, 2026 | Ra Capital Management L.p. (Insider) | Sold (not open market) | $1B |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $15M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $6M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $5.9M |
| Jan 7, 2026 | Shane Ward (COO) | Sold (not open market) | $5.6M |
| Jan 7, 2026 | Nicole Negar Davarpanah (C-suite exec) | Sold (not open market) | $2.8M |
| Jan 7, 2026 | Frank Karbe (CFO) | Sold (not open market) | $2.4M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $1.7M |
| Jan 7, 2026 | Frank Karbe (CFO) | Sold (not open market) | $1.7M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $1.6M |
| Jan 7, 2026 | Shane Ward (COO) | Sold (not open market) | $1.5M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $1.3M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $1.3M |
| Jan 7, 2026 | Shane Ward (COO) | Sold (not open market) | $1.1M |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $940K |
| Jan 7, 2026 | Chrysa Mineo (Director) | Sold (not open market) | $735K |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $712K |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $692K |
| Jan 7, 2026 | Nicole Negar Davarpanah (C-suite exec) | Sold (not open market) | $673K |
| Jan 7, 2026 | Nicole Negar Davarpanah (C-suite exec) | Sold (not open market) | $646K |
| Jan 7, 2026 | Joshua Resnick (Director) | Sold (not open market) | $591K |
| Jan 7, 2026 | Ra Capital Management L.p. (Insider) | Sold (not open market) | $591K |
| Jan 7, 2026 | Jeffrey Stein (CEO) | Sold (not open market) | $549K |
| Jan 7, 2026 | Shane Ward (COO) | Sold (not open market) | $540K |
Who's trading CDTX
- Shane Ward, COO: sold $2.2M (1 sale), last Jan 7, 2026
- Bonnie L Bassler, Director: other filings, last Jan 7, 2026
- Carin Canale-Theakston, Director: other filings, last Jan 7, 2026
- Nicole Negar Davarpanah, C-suite exec: other filings, last Jan 7, 2026
- Frank Karbe, CFO: other filings, last Jan 7, 2026
- James Merson, Director: other filings, last Jan 7, 2026
- Chrysa Mineo, Director: other filings, last Jan 7, 2026
- Ra Capital Management L.p., Insider: other filings, last Jan 7, 2026
- Joshua Resnick, Director: other filings, last Jan 7, 2026
- Theodore R Schroeder, Director: other filings, last Jan 7, 2026
- Ryan Spencer, Director: other filings, last Jan 7, 2026
- Jeffrey Stein, CEO: other filings, last Jan 7, 2026
- Daniel D Burgess, Director: other filings, last Jan 7, 2026
Get free alerts when an insider at Cidara Therapeutics, Inc files a new trade →